Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients

Journal of Oncology Pharmacy Practice

Volumn 18, Issue 2, 2012, Pages 311-315

  Kim, Sophie ^a   Tannock, Ian ^a   Sridhar, Srikala ^a   Seki, Jack ^a   Bordeleau, Louise ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Cyclophosphamide; gemcitabine; infiltrative pneumonitis; interstitial pneumonitis; taxane

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FUROSEMIDE; GEMCITABINE; METHYLPREDNISOLONE; PACLITAXEL; PAMIDRONIC ACID; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC PNEUMONITIS; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; BREAST CANCER; BREAST CARCINOMA; BREAST METASTASIS; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMOTHERAPY INDUCED INTERSTITIAL PNEUMONIA; CHILL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; COUGHING; DIFFERENTIAL DIAGNOSIS; DRUG FEVER; DRUG INDUCED DISEASE; DYSPNEA; FATIGUE; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL RESIDUAL CAPACITY; HIGH RISK PATIENT; HUMAN; INSPIRATORY CAPACITY; INTERSTITIAL PNEUMONIA; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG NODULE; LUNG VOLUME; ORGANIZING PNEUMONIA; OXYGEN SATURATION; PREMENOPAUSE; PRIORITY JOURNAL; RESIDUAL VOLUME; THORAX PAIN; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; URINE CULTURE; VIRUS INFECTION; VITAL CAPACITY; WEAKNESS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PACLITAXEL; TAXOIDS;

EID: 84871787058     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/1078155211429384     Document Type: Article

References (28)

1. Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004 ; 71: 301-326
2. Cleverley JR, Screaton NJ, Hiorns MP, Flint JDA, Muller NL. Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol. 2002 ; 57: 292-299
3. Ellis SJ, Cleverley JR, Muller NL. Drug-induced lung disease: high-resolution CT findings. AJR. 2000 ; 175: 1019-1024
4. Hasskarl J, Schroettner P, von den Berg A, Rueckert A, Frydrychowicz A, Kayser G, et al. Severe organizing pneumonia after two cycles of docetaxel as fourth-line chemotherapy for advanced non-small cell carcinoma of the lung. Case Rep Oncol. 2009 ; 2: 12-19
5. Read WL, Mortimer JE, Picus J. Severe interstitial pneumonitis associated with docetaxel administration. Cancer. 2002 ; 94 (3). 847-853
6. Wang GS, Yang KY, Perng RP. Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere). British J Cancer. 2001 ; 85 (9). 1247-1250
7. Merad M, Le Cesne A, Baldeyrou P, Besurolle B, Le Chevalier T. Docetaxel and interstitial pulmonary injury. Ann Oncol. 1997 ; 8: 191-194
8. Ramanathan RK, Reddy VV, Holbert JM, Belani CP. Pulmonary infiltrates following administration of paclitaxel. Chest. 1996 ; 110: 289-292
9. Gupta N, Ahmed I, Steinberg H, Patel D, Nissel-Horowitz S, Mehrotra B. Gemcitabine-induced pulmonary toxicity: case report and review of the literature. Am J Clin Oncol (CCT). 2002 ; 25 (1). 96-100
10. Barlesi F, Villani P, Doddoli C, Gimenez C, Kleisbauer JP. Gemcitabine-induced severe pulmonary toxicity. Fundam Clin Pharmacol. 2004 ; 18: 85-91
11. Marruchella A, Fiorenzano G, Merizzi A, Rossi G, Chiodera PL. Diffuse alveolar damage in a patient treated with gemcitabine. Eur Respir J. 1998 ; 11: 504-506
12. Docetaxel product monograph, Sanofi-Aventis. www.sanofi-aventis.ca/ products/en/taxotere.pdf (accessed January 2011).
13. Paclitaxel product monograph, Bristol-Myers Squibb. www.bmscanada.ca/ static/products/en/pm-pdf/taxol/-en-pm.pdf (accessed January 2011).
14. Kuip E, Muller E. Fatal pneumonitis after treatment with docetaxel and trastuzumab. Neth J Med. 2009 ; 67 (6). 237-239
15. Ostoros G, Pretz A, Fillinger J, Soltesz I, Dome B. Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature. IGCS. 2006 ; 16 (Suppl. 1). 391-393
16. Wong P, Leung AN, Berry GJ, Atkins KA, Montoya JG, Ruoss SJ, et al. Paclitaxel-induced hypersensitivity pneumonitis: radiographic and CT findings. AJR. 2001 ; 176: 718-720
17. Biswas S, Nik S, Corrie PG. Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease. Clin Oncol. 2004 ; 16: 577-579
18. Pavlakis N, Bell DR, Millward MJ, Levi JA. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer. 1997 ; 80 (2). 286-291
19. Rossi S, Erasmus J, McAdams P, Sporn T, Goodman P. Pulmonary drug toxicity: radiologic and pathologic manisfestations. Radiographics. 2000 ; 5: 1245-1259
20. Segura A, Yuste A, Cercos A, Lopez-Tendero P, Girones R, Perez-Fidalgo JA, et al. Pulmonary fibrosis induced by cyclophosphamide. Ann Pharmacother. 2001 ; 35: 894-897
21. USP DI. Drug Information for the healthcare professional. Update monographs. Cyclophosphamide. Micromedex, Inc., www.micromedex.com (accessed January 2011).
22. USP DI. Drug Information for the healthcare professional. Update monographs. Doxorubicin. Micromedex, Inc., www.micromedex.com (accessed January 2011).
23. USP DI. Drug Information for the healthcare professional. Update monographs. Pamidronate. Micromedex, Inc., www.micromedex.com (accessed January 2011).
24. Camus Ph, Foucher P, Bonniaud Ph, Ask K. Drug-induced infiltrative lung disease. Eur Respir J. 2001 ; 18 (Suppl. 32). 93s - 100s
25. Rosado MF, Kett DH, Schein RM, Baraona FJ, Sridhar KS. Severe pulmonary toxicity in a patient treated with gemcitabine. Am J Clin Oncol. 2002 ; 25 (1). 31-33
26. USP DI. Drug Information for the healthcare professional. Update monographs. Bleomycin. Micromedex, Inc., www.micromedex.com (accessed January 2011).
27. Dimopoulou I, Efstathiou E, Samakovli A, Dafni U, Moulopoulos LA, Papadimitriou C, et al. A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment. Ann Oncol. 2004 ; 15 (8). 1250-1255
28. Kim S, Bordeleau L, Tannock I, Rotstein C. A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab. J Oncol Pharm Pract. Epub ahead of print 12 September 2011. DOI: 10.1177/1078155211412991. :